Background: Laparoscopically procured live donor kidney grafts are increasingly transplanted into pediatric recipients. The safety and efficacy of this changed surgical practice are unknown.
D
URING THE past 4 decades, live donor renal t r a n s p l a n t a t i o n h a s emerged as the treatment of choice for nearly all children with end-stage renal disease. 1 Live donor transplants are associated with fewer technical graft failures, better short-and long-term function, and superior recipient growth and development than cadaver transplants. [1] [2] [3] Moreover, a live donor may allow for preemptive transplantation, thus obviating dialysis access-related morbidity and the long waiting times for cadaver grafts. Hence, it is not surprising that in 1999, 52% of all kidney transplants in recipients less than 18 years of age in the United States were from live donors. 4 In contrast to the standardized pediatric recipient implantation technique, 5 the surgical approach to live donors has recently undergone significant changes since the introduction of laparoscopic nephrectomy, first described in 1995. 6, 7 Currently, more than 60% of all live donor nephrectomies in the United States are performed laparoscopically. Studies [8] [9] [10] [11] [12] [13] [14] [15] have shown that compared with the conventional open technique, laparoscopic nephrectomy results in less postoperative pain, shorter length of hospital stay, faster return to work, and higher donation rates. However, operative-technical limitations inherent in minimally invasive surgery and in the pneumoperitoneum required for laparoscopy may have a detrimental impact on graft quality [16] [17] [18] ; in adult recipients of laparoscopic donor kidneys, some investigators 9, 12, 13, 15, 19 have observed higher vascular and ureteral complication rates and slower early postoperative graft func-PAPER tion. In pediatric recipients, however, technical and functional outcomes of laparoscopic live donor kidney grafts have not been well characterized, 20 and the safety and efficacy of the laparoscopic procurement have yet to be demonstrated. Simple extrapolation of adult data to pediatric recipients is not appropriate, as pediatric renal transplants pose unique challenges, including operativetechnical aspects, hemodynamics at the time of graft reperfusion, and increased immune reactivity (compared with adults), resulting in higher rejection rates. [1] [2] [3] 5, 21 At the University of California, Davis, Medical Center, we began the current pediatric renal transplantation program in 1991. Initially, we used an open flank incision to procure all live donor kidney grafts. Since inception of the laparoscopic nephrectomy program in 1997, all live donor grafts transplanted into pediatric recipients have been procured laparoscopically.
The purpose of this study is to analyze the pediatric renal transplantations performed with laparoscopically procured live donor kidneys, particularly with regard to posttransplantation graft function and recipient surgical complications. For comparison, we used a historic open live donor pediatric recipient cohort pair matched for age with the laparoscopic cohort. We also 
PATIENTS, MATERIALS, AND METHODS

PATIENTS
PREOPERATIVE DONOR EVALUATION
During the preoperative donor evaluation, medical, surgical, and psychosocial suitability for live donation was assessed. Detailed informed consent was obtained. Imaging studies for delineation of renal and retroperitoneal anatomy included ultrasonography and conventional renal arteriography for open donors, and 3-dimensional computed tomography angiography combined with conventional renal arteriography or magnetic resonance angiography for laparoscopic donors. All donor-recipient pairs were T-cell crossmatch compatible and ABO blood-type compatible.
OPEN NEPHRECTOMY TECHNIQUE
All open nephrectomies were performed using a standardized (extraperitoneal) subcostal flank approach with or without rib resection as previously described. 5 Throughout the operation, fluids were liberally administered, and furosemide and mannitol were given intravenously at the discretion of the surgeon before division of the renal artery. The kidneys were flushed with lactated Ringer solution or EuroCollins solution at 4°C immediately after extraction and were preserved on ice until implantation. The backtable ex vivo kidney preparation was done in either the donor or recipient operating room. Arterial or venous extension grafts were not used. Donor operating time was calculated as the time from incision to skin closure.
LAPAROSCOPIC NEPHRECTOMY TECHNIQUE
The operation was performed as previously described. 16 The hand-assisted laparoscopic technique was not used. For leftsided nephrectomy, a Foley catheter was inserted at the beginning of the operation, and the donor was placed in a right lateral decubitus position. Throughout the operation, fluids were administered to maintain the donor's urine output at 2 mL/kg per hour. Furosemide and mannitol were administered intravenously at the discretion of the surgeon before division of the renal artery.
After appropriate abdominal insufflation with carbon dioxide to reach a maximal intra-abdominal pressure of 15 mm Hg, 3 laparoscopic ports were placed along the left paramedian line. The entire laparoscopic dissection was performed using an ultrasonic dissector. The left colon, including the splenic flexure, was mobilized, and the splenorenal ligament was divided, allowing the spleen to fall back into the upper abdomen. Next, we mobilized the upper kidney pole.
Before continuing the dissection, an additional port was placed subcostally in the left posterior axillary line, and a hook retractor was inserted, allowing retraction of the kidney laterally, gently stretching the renal artery and vein. The renal vein was identified, and the gonadal and adrenal vein were dissected, clip ligated, and divided. The renal artery was identified at its aortic takeoff and was freed from all periarterial ganglionic and lymphatic tissues.
Then, the ureter was dissected using a no-touch technique. The dissection was started in a plane medial to the gonadal vein. We did not insist on visualizing the ureter at this point; the periureteral fatty tissue in the infrapolar perirenal area was left intact to minimize the potential for ureteral devascularization. Dissection was carried further down to the point where the left ureter crosses the left common iliac artery. Here, the ureter was visualized, and its future distal transection point was identified.
A transverse Pfannenstiel incision centered on the midline was made suprapubically. A laparoscopic specimen retrieval bag device was inserted into the peritoneum through a purse-string suture. The abdomen was reinsufflated, and the patient was rotated back into the right lateral decubitus position. Intravenous heparin sodium was given (70-U/kg bolus), and the ureter was transected distally after clipping the distal portion.
Next, we transected the renal artery after applying a laparoscopic linear noncutting stapler (Multi fire ENDO 
RESULTS
GRAFT CHARACTERISTICS AND DONOR OUTCOMES
In all, 20 (91%) of the 22 kidneys were donated by a parent (18 by a biologic mother or father and 2 by an unrelated stepmother) ( Table 2) . Demographics for open and laparoscopic donors were not significantly different ( Table 2) .
Of the 22 grafts, 17 (77%) were left kidneys and 5 (23%) were right kidneys (right-sided nephrectomies: open, n=3; laparoscopic, n=2; PϾ.05) ( Table 3) . We noted multiple renal arteries in 6 (27%) of the 22 grafts included in this analysis (Table 3 ). All 6 of the multipleartery grafts had 2 arteries. Surgical management of the multiple arteries consisted of a side-to-side anastomosis ("pants" technique) in 3 patients (50%), end-to-side reimplantation of the smaller artery into the main renal artery in 1 (17%), separate anastomoses for both vessels to the recipient's infrarenal aorta in 1 (17%), and ligation of a small upper polar artery in 1 (17%). None of TA 30 2.5; United States Surgical Corp, Norwalk, Conn) as close as possible to its aortic takeoff. This phase of the operation was considerably facilitated by the hook retractor placed in the posterior axillary line, allowing placement of the vascular stapler as near as possible to the aorta and inferior vena cava, respectively, by gently stretching the vascular pedicle, thus maximizing graft vessel length. The stapler was reloaded and applied to the renal vein, which was also transected. The kidney was placed into the laparoscopic retrieval bag and extracted through the Pfannenstiel incision. The extracted kidney was flushed, preserved, and prepared for transplantation as described for open nephrectomy. Operating time was calculated as described for open nephrectomy.
RECIPIENT OPERATION
In small children (approximately Ͻ15 kg), the graft was placed intra-abdominally in a right retrocolic position through a midline incision, as described previously. 5 The renal artery and renal vein were anastomosed to the recipient's infrarenal abdominal aorta and inferior vena cava, respectively. In larger children, the graft was usually placed extraperitoneally into the right or left iliac fossa or flank with renal artery and vein anastomoses to the external or common iliac artery and external or common iliac vein or distal inferior vena cava, respectively.
Intraoperatively, central venous pressures were routinely monitored via a central venous catheter. Before graft reperfusion, intravenous fluids were given to elevate the central venous pressure to 15 to 18 cm H 2 O, and the systemic blood pressure was brought to the recipient's preoperative baseline level. In addition, furosemide (1 mg/ kg) and mannitol (250 mg/kg) were given intravenously at that time. During reperfusion, the kidney graft was warmed by topical irrigation with warm (37°C) isotonic sodium chloride solution.
Ureteral drainage was reestablished using an intravesical (Leadbetter-Politano) ureteroneocystostomy in smaller children or an extravesical single-or multiplestitch technique in larger recipients. 5 Ureteral stents were not routinely used.
POSTOPERATIVE RECIPIENT MANAGEMENT
Intravenous diuretics were administered according to urine output as previously described. 5 Platelet aggregation inhibitors and anticoagulating agents were not routinely given. Until December 31, 1997, immunosuppression consisted of azathioprine, a prednisone taper, and a 7-to 10-day induction course of murine monoclonal antilymphocyte antibody (muromonab-CD3) or polyclonal antithymocyte globulin. Cyclosporine therapy was started sequentially once the recipient's serum creatinine level had fallen below 2.0 mg/dL (177 µmol/L). Since January 1, 1998, the immunosuppressive protocol has included tacrolimus, mycophenolate mofetil, a prednisone taper, and perioperative administration of an interleukin-2 receptor antibody (basiliximab or daclizumab).
Rejection episodes (diagnosed clinically or by biopsy) were treated with intravenous corticosteroid pulse therapy or an oral prednisone taper. Histologically severe and all corticosteroid-resistant rejections were treated with a 5-to 7-day course of murine monoclonal antilymphocyte antibody or polyclonal antithymocyte globulin. In cases of delayed graft function, a biopsy was obtained 7 days after transplantation and then every 7 to 10 days until renal function was adequate.
Early relaparotomy was defined as any laparotomy performed during the first 6 weeks after transplantation.
GRAFT FUNCTION ANALYSIS
Urine outputs were recorded on postoperative days 1 and 2. Serum creatinine levels were measured before transplantation and then after transplantation on days 1 through 6; at 1, 3, and 6 months; and yearly thereafter. The estimated standardized creatinine clearance was determined by using a pediatric nomogram. 22 Dialysis was performed as needed in the posttransplantation period according to the patient's clinical status and laboratory findings. Delayed graft function was defined as the need for at least 1 dialysis session during the first 7 days after transplantation.
STATISTICAL ANALYSIS
Donor and recipient demographic and outcome variables were compared between the open and laparoscopic donor groups. Categorical variables were analyzed using the the anatomical characteristics were significantly different between the open and laparoscopic donor kidneys (Table 3) . Warm ischemia time for the recipients was not significantly different between groups (Table 3) . Laparoscopic graft procurement was associated with longer donor operative time (P = .08) ( Table 3 and Figure 1) .
One laparoscopic donor (9%) developed intraoperative bleeding from a preoperatively unidentified accessory renal vein and had to be converted to open nephrectomy. There were no other conversions or intraoperative or perioperative donor complications. None of the donors required blood transfusion or hospital readmission. Median postoperative length of hospital stay was significantly shorter for laparoscopic donors (P=.02) ( Table 3) .
RECIPIENT OUTCOMES
Recipient demographics did not differ significantly between groups (Table 4) . Median follow-up was 2902 days for open vs 613 days for laparoscopic donor recipients (P=.01).
After transplantation, all open donor vs only 3 laparoscopic donor kidney recipients received cyclosporine (100% vs 27%; P=.001). Immunosuppression for the remaining 8 laparoscopic kidney recipients (73%) consisted of a tacrolimus-based regimen.
There was no incidence of vascular graft thrombosis in the laparoscopic group. In all, 4 ureteral complications (18%) occurred (3 in the laparoscopic donor group vs 1 in the open donor group; PϾ.05), including 1 late distal ureteral stenosis 3.7 years after transplantation caused by chronic rejection ( Table 5 ). The early relaparotomy rate was similar for both groups (PϾ.05) ( Table 5 ). Recipient survival was 100%.
QUALITY OF GRAFT FUNCTION
There was no significant difference in immediate posttransplantation urine output between study groups ( Table 6) (Figure 3) . Delayed function occurred in 1 laparoscopic graft recipient ( Table 6 ). In that particular case, the delayed function had resulted from immediate postoperative transplant ureter obstruction (ureteroneocystostomy torsion) and resolved after surgical revision.
REJECTION AND GRAFT SURVIVAL
Rejection rates were not statistically significantly different between open and laparoscopic donor kidney recipients (Table 6 ). In all, we noted only one graft loss (in the laparoscopic donor group). The cause of graft loss 3.8 years after transplantation was chronic rejection. Graft survival at 1 and 3 years was 100% for both groups (PϾ.05).
COMMENT
In pediatric renal transplantation, the currently available data support the preferential use of grafts from live donors. [1] [2] [3] Facilitated by the introduction of laparoscopic nephrectomy, live kidney donation rates have been increasing recently. 4, 14 According to a survey, a significant proportion of transplantation centers performing live donor kidney transplantations have adopted the minimally invasive technique and believe that it will become the standard of care. 7 For adult recipients, laparoscopic donor nephrectomy has been established as safe and efficacious. [8] [9] [10] [11] [12] [13] [14] [15] [16] However, for pediatric recipients, laparoscopic donor kidney outcomes have not been reported in detail. We found only one published study 20 (an abstract) investigating laparoscopic nephrectomy for pediatric renal transplantation; the authors noted similar posttransplant serum creatinine levels for recipients of laparoscopic vs open live donor kidney grafts. However, in children, creatinine levels may not be discriminatory enough to reveal subtle differences in posttransplantation graft function, and the potential adverse impact of laparoscopic nephrectomy on surgical complications in pediatric recipients also is unclear.
The lack of data supporting the shift of surgical practice toward laparoscopic nephrectomy prompted us to review our own experience by comparing our current laparoscopic graft outcomes with our historic open live donor pediatric renal transplantation outcomes. Because glomerular filtration rates are age dependent, and recipient age at transplantation has been noted by previous investigators 1, 2, 22 to be a significant independent predictor of graft survival, we age matched all of the laparoscopic recipients with open donor recipients. We assessed early graft function by using the estimated standardized creatinine clearance to estimate glomerular filtration rate, which has been shown to be a valid outcome variable in pediatric kidney recipients. 23 All donor kidneys were from adults and thus had comparable nephron masses, minimizing the potential impact of an important variable that may affect longterm outcome. Finally, the 2 study groups were demographically homogeneous, particularly with respect to dialysis mode at transplantation, race, and retransplantation status, all significant predictors of graft survival. 1, 2 As previously stated, we believe that extrapolation of laparoscopic live donor graft outcome results from adult recipients to pediatric recipients is not possible. Laparoscopic procurement may have detrimental nonimmunologic and immunologic consequences and could imperil the good outcomes that can now be achieved with live donor grafts in pediatric patients for the following 3 reasons.
First, the graft loss rate from vascular thrombosis is highest in pediatric recipients, for whom graft thrombosis remains the third most common cause of graft failure. [1] [2] [3] Transplantation of a large adult kidney into a small child poses a significant hemodynamic challenge, and adequate recipient aortic blood flow during transplantation is crucial for optimal graft reperfusion. 21 The longer donor operative times and the associated longer exposure of the kidney to surgical manipulation during the laparoscopic dissection may lead to increased tissue injury and impaired postreperfusion graft microcirculation and may result in renal parenchymal edema, all of which may increase graft thrombosis and infarction rates. 10, 11, 16 Pneumoperitoneum during laparoscopy can affect renal blood flow and theoretically may cause a higher propensity for vascular thrombosis because of the temporary relative venous stasis in the donor's renal vein during laparoscopy and the endothelial injury sustained from increased vein distention. 17, 18, 24 Moreover, laboratory evidence of postoperative hypercoagulability after laparoscopic cholecystectomy was noted by Caprini et al. 25 Consistent with this scenario, a case of native renal vein thrombosis after laparoscopic cholecystectomy was recently reported. 26 Also, several investigators 16, 27 have described higher multiple renal artery rates in laparoscopically procured kidneys; these usually require additional surgical reconstruction. These higher multiple renal artery rates are due to the preference of laparoscopic surgeons for the left kidney (irrespective of its number of renal arteries) secondary to the longer left renal vein. In addition, a laparoscopic stapler cannot be placed as close to the aorta and inferior vena cava as an openly applied clamp. A single renal artery with an early bifurcation, therefore, may become a double renal artery after the stapler has been fired. Because laparoscopic staplers are introduced from a distance and at an angle to the renal artery and renal vein, not all potentially available vascular length may be obtained. Moreover, the width of the vascular stapler is generally greater than the width of an openly placed conventional vascular clamp, diminishing the amount of vessel length available at implantation. All these anatomical-technical factors can result in a higher incidence of grafts with multiple renal arteries and shorter vessel length. 16 Vascular complications that have been described for grafts with multiple renal arteries include graft thrombosis and a higher incidence of early ureteral complications. In addition, particularly in smaller pediatric recipients, sufficient available donor vessel length is paramount to avoid torsion and kinking and to optimize alignment of the renal artery and vein in the face of restricted intra-abdominal spatial flexibility. 3, 5 Thus, in pediatric recipients, laparoscopically procured kidney grafts may be at higher risk for early graft failure from thrombosis and infarction. We did not observe a single technical graft loss in laparoscopic donor recipients, although the incidence of multiple renal arteries was twice as high as in the open donor group. Based on our analysis, we believe that application of the previously outlined intraoperative donor and recipient management principles in combination with standard surgical implantation and reconstruction techniques is safe for pediatric recipients. No technical modifications with respect to the recipient operation seem to be necessary when transplanting laparoscopically procured kidneys. Finally, we expect the higher incidence of multiple renal arteries in the laparoscopic era to diminish because we 16 recently successfully started to implement right-sided laparoscopic nephrectomy (as in 2 donors in this series).
Second, pediatric recipients have a higher rate of congenitally diseased urinary outflow tracts with or without the need for operative revision before transplantation. For laparoscopically procured grafts, some authors have described higher posttransplantation ureteral complication rates in adult recipients, which may be related to surgical trauma (eg, ureteral devascularization) at the time of procurement. [7] [8] [9] 15 Any impairment of the transplant ureter as a result of the donor operation may therefore be particularly disadvantageous to pediatric recipients. We noted a 27% ureteral complication rate in laparoscopic recipients vs a 9% rate in open donor recipients. However, closer analysis of our experience in- dicates that of all 3 ureteral complications in the laparoscopic group, only 1 (an early leak) was potentially attributable to laparoscopic procurement. The second ureteral complication was related to a technical error occurring during the recipient operation (ureteroneocystostomy torsion). The third ureteral complication (a late distal ureteral stenosis Ͼ3 years after transplantation) was related to chronic rejection; the kidney graft also failed from chronic rejection within 1 month after the distal ureter stenosis was diagnosed. Thus, we did not find any substantial evidence that laparoscopic nephrectomy increases ureteral complication rates. We believe that careful periureteral dissection in the donor, leaving a large amount of periureteral tissue intact and avoiding stripping the ureter, is paramount for achieving low ureteral complication rates for pediatric and adult recipients.
Third, with respect to graft function, several studies 9, [11] [12] [13] 15 have shown slower early posttransplantation function for laparoscopic (vs open) grafts when analyzing recipients' serum creatinine levels. However, this difference was not observed on all posttransplantation days, did not persist beyond the first month, and did not achieve statistical significance at all times in all studies. In our pediatric analysis, there was also a trend toward slower initial posttransplantation recovery of renal function (measured by estimated glomerular filtration rates and serum creatinine levels) for laparoscopic grafts. However, by 1 month after transplantation, and at all later follow-up times, graft function was similar in both groups. Most laparoscopic graft recipients received tacrolimus (vs cyclosporine for all open donor graft recipients). Given the study design, it was not possible to determine whether the observed initial functional differences can be attributed solely to the laparoscopic procurement (eg, to the adverse effects of pneumoperitoneum on renal cortical blood flow) or to the sequential immunosuppressive protocol with delayed calcineurininhibitor administration that was exclusively used for the open donor group or if potential differential nephrotoxic adverse effects of tacrolimus vs cyclosporine may have contributed to our findings. 17, 18 Because the stringent hemodynamic goals required for good immediate function in children cannot always be met, any potential additional impairment of posttransplantation graft function as a result of the laparoscopic procurement may be particularly disadvantageous to them. Early graft function is the most sensitive noninvasive clinical variable available to assess the degree of early graft injury. Increased immunologic graft losses after nonimmunologic, nonspecific graft injury as evidenced by slower initial graft function may result from the injury-inflammation-immune recognition triangle proposed by Halloran et al 28, 29 . In line with this postulated cycle, it is now well established that early graft injury, as manifested by delayed function, is associated with increased acute rejection rates also in pediatric recipients and constitutes a significant risk factor for chronic rejection and poor long-term graft survival. 30, 31 Because pediatric recipients have higher acute rejection rates than adults, any potential long-term consequences related to the magnitude of early graft injury may become particularly apparent. In our analysis, delayed function rates were not significantly different between the 2 study groups, and we were not able to document any significant differences in immunologic outcomes (incidence of acute rejection and immunologic graft loss). However, our study was limited by sample size and by the fact that rejection episodes were not consistently biopsy proven. Moreover, with 100% graft survival 3 years after transplantation in both groups, any differences in immunologic outcomes for laparoscopic vs open donor grafts may be difficult to demonstrate and must await further analysis in larger study populations with longer follow-up. In summary, we believe that the subtle differences in early posttransplantation graft function underscore the importance of strict adherence to management principles that have been shown to be renoprotective in previous studies, 17, 32 including aggressive intravenous volume replacement during donor nephrectomy and targeting specific intraoperative recipient hemodynamic goals.
What are the implications of laparoscopic nephrectomy for donors? First and most important, laparoscopic donors had a significantly shortened postoperative length of hospital stay. It is likely that this shortened length of stay is associated with faster convalescence, faster return to usual activities of daily life, and faster return to work, as previously reported. 8, 10 In this context, it is particularly important to note that, as in many other live donor pediatric renal transplantation studies, more than 90% of our donors were parents of the recipients. Shorter postdonation hospital stay and likely shortened postdischarge convalescence allow the donors to return faster to their ongoing family obligations with respect to child and recipient care. Laparoscopic nephrectomy, therefore, also is likely to further enhance the previously reported 33, 34 high postdonation satisfaction scores after open nephrectomy and the improved relationship between live kidney donors and their pediatric recipients. Because of the retrospective nature of this study, we did not assess the 2 donor populations for differences in postoperative analgesic requirements and postsurgical pain.
Second, we noted longer donor operative times for laparoscopic nephrectomies. Renal transplants from laparoscopic live donors may thus slightly postpone the breakeven point (time required before the transplantation cost is recovered by saving the cost of dialysis). 35 However, because we used historic controls, we could not perform a comparative economic analysis. Such an analysis would need to establish whether the added costs for the higher operating room and anesthesia charges, as well as the disposable laparoscopic instruments used for laparoscopic nephrectomy, outweigh the benefit of the shorter postdonation hospitalization.
This study has several limitations. From an immunologic outcome perspective, it encompasses 2 different immunosuppressive eras with different recipient immunosuppressive protocols. Furthermore, rejection episodes were not systematically biopsy proven. Given the study design, follow-up observation times in the 2 groups were significantly different, and there was a relatively small proportion of laparoscopic donor grafts with more than 2 years of follow-up. For these reasons, we caution against overinterpreting the results with respect to long-term immunologic outcomes. Last, our sample size was small owing to the recent introduction of the laparoscopic technique, but this study represents the most comprehensive published analysis and the largest single-center experience available on the subject, to our knowledge.
In conclusion, we observed no detrimental impact of laparoscopic live donor nephrectomy on pediatric recipient outcome. Laparoscopic nephrectomy was also safe for our live kidney donors, and it shortened their postoperative length of stay significantly. We believe that these findings justify the continued application of laparoscopic live donor nephrectomy in pediatric renal transplantation for now. However, further research on larger patient populations with longer follow-up times is necessary for definitive confirmation of these findings. 
